WHO ICTRP trial
Study to determine if contacting patients with Medullary Thyroid Cancer (MTC)…
CTRI/2011/07/001930 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2011/07/001930 |
|---|---|
| Public title | Study to determine if contacting patients with Medullary Thyroid Cancer (MTC) more frequently results in earlier detection and treatment of signs and symptoms of AEs and thus a decrease in the percentage of time patients experience AEs during first 12 months on vandetanib treatment. |
| Scientific title | A Randomized, International, Open-Label Phase III Study to Assess the Effect of a Patient Outreach Program on the Percentage of Time Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC) Experience Grade 2 or Higher AEs in the First 12 Months of Treatment With Vandetanib… |
| Primary sponsor | AstraZeneca |
| Secondary sponsors | AstraZeneca Pharma India Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | Australia;Austria;Belgium;Brazil;Bulgaria;Canada;China;Czech Republic;Denmark;Finland;Germany;Greece;India;Israel;Italy;Poland;Republic of Korea;Russian Federation;Sweden;United Kingdom |
| Conditions | Health Condition 1: null- Medullary Thyroid Cancer |
| Interventions | Intervention1: 300mg vandetanib: Experimental - treatment 300mg vandetanib open label Intervention: Behavioral: Patient outreach Intervention2: Vandetanib: Behavioral: Patient outreach Patients will be contacted at week 1 and then every 2… |
| Registration date | Jul 29, 2011 |
| Target size | 206 |
| Secondary IDs | D4200C00088;NCT01298323 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: